|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
1 Department of Life Science, Swiss Federal Institute of Technology, CH-1015, Lausanne, Switzerland
2 Department of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California
3 Department of Life Science, Swiss Federal Institute of Technology, Lausanne, Switzerland; The Burnham Institute, 10901 North Torrey Pines Rd, La Jolla, California
* To whom correspondence should be addressed. E-mail: terskikh{at}burnham.org.
| Abstract |
|---|
We have generated a transgenic mouse line, which allows for simple and highly efficient enrichment for mouse hematopoietic stem cells (HSCs). The transgene expresses a GFP variant (zFP) under the control of H2Kb promoter/enhancer element. Despite the broad z FP expression, transgenic HSCs express exceptionally high levels of zFP, al-lowing prospective isolation of a population highly enriched in HSCs by sorting the 0.2% of the brightest green cells from the enriched bone marrow of H2K-zFP mice. Up to 90% of zFPbright cells are also c-kithigh, Sca-1high, Linneg, Flk-2neg, which is a bona fide pheno-type for long-term HSCs. Double sorted zFPbright HSCs were capable of long-term multi-lineage reconstitution at a limiting dilution dose of about 12 cells, which is comparable to that of highly purified HSCs obtained by conventional multicolor flow cytometry. Thus, the H2K-zFP transgenic mice provide a straightforward and easy setup for the simple and highly efficient enrichment for genetically-labeled HSCs without using fluorescence-conjugated monoclonal antibodies. This approach will greatly facilitate gene transfer, in-cluding siRNA for gene knock-down, into HSCs and, consequently, into all other hema-topoietic lineages.
This article has been cited by other articles:
![]() |
N. Hosen, T. Yamane, M. Muijtjens, K. Pham, M. F. Clarke, and I. L. Weissman Bmi-1-Green Fluorescent Protein-Knock-In Mice Reveal the Dynamic Regulation of Bmi-1 Expression in Normal and Leukemic Hematopoietic Cells Stem Cells, July 1, 2007; 25(7): 1635 - 1644. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
